Sg Americas Securities, LLC Pacira Bio Sciences, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 19,847 shares of PCRX stock, worth $443,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,847
Previous 25,254
21.41%
Holding current value
$443,778
Previous $380,000
1.58%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
50.1MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$179 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$118 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$111 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$45 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$44.3 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.02B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...